YME-13103-29192 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-31
Dose 1 — Pfizer-BioNTech
2021-01-21
Registered in v-safe
2021-01-21
Dose 2 — Pfizer-BioNTech
2021-01-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-24
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-25
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-27
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-28
Survey response — day 7, dose 2
MedDRA: Cough — Feeling: Fair · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Cough

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-04
Survey response — day 14, dose 2
MedDRA: Chills, Night sweats — Feeling: Fair

Free text: Chills, night sweats

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-11
Survey response — day 21, dose 2
MedDRA: Chills, Cough, Ear pain, Eyelid disorder, Fatigue, Muscular weakness, Night sweats, Pre-existing disease, Tinnitus, Visual impairment — Feeling: Poor · Be unable to do your normal daily activities

Free text: Earache, increased tinnitus in opposite ear Increased coughRepetitive chills during the daytime, then severe night sweats Extreme fatigue and some weakness of muscles Difficulty focusing eyes- reading/working at computer May go to UC

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-18
Survey response — day 28, dose 2
MedDRA: Chills, Disturbance in attention, Ear pain, Fatigue, Night sweats, Vision blurred — Feeling: Fair · Be unable to do your normal daily activities

Free text: Ear pain, intermittent difficulty focusing right eye, night sweats continue and chills during the daytime continue. (I live in Arizona so it is NOT cold or chilly here). Fatigue and difficulty concentrating

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-31	Pfizer-BioNTech
2	2021-01-21	Pfizer-BioNTech

Free text

Release 3 — day 7, dose 2

2021-01-28

Systemic reaction (other): Cough

Release 3 — day 14, dose 2

2021-02-04

Symptoms: Chills, night sweats

Release 4 — day 21, dose 2

2021-02-11

Symptoms: Earache, increased tinnitus in opposite ear Increased coughRepetitive chills during the daytime, then severe night sweats Extreme fatigue and some weakness of muscles Difficulty focusing eyes- reading/working at computer May go to UC

Release 4 — day 28, dose 2

2021-02-18

Symptoms: Ear pain, intermittent difficulty focusing right eye, night sweats continue and chills during the daytime continue. (I live in Arizona so it is NOT cold or chilly here). Fatigue and difficulty concentrating

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Chills	✓	✓	✓
SD	Cough	✓	✓	✓
SD	Disturbance in attention	✓	✓	✓
SD	Ear pain	✓	✓	✓
SD	Eyelid disorder	○	✓	○
SD	Fatigue	✓	✓	✓
SD	Muscular weakness	✓	✓	✓
SD	Night sweats	✓	✓	✓
SD	Pre-existing disease	✓	·	✓
SD	Tinnitus	✓	✓	✓
SD	Vision blurred	✓	✓	✓
SD	Visual impairment	✓	·	✓
SRO	Cough	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release